MarketCap
Facebook
X
TelegramGeschäftsbericht 2021
hinzugefügt 23.12.2023
Zealand Pharma A/S DSO 2011-2026 | ZEAL
DSO Jährlich Zealand Pharma A/S
| 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | 75.3 | 83.9 | - | - | - | - | - | - |
Alle Zahlen in DKK-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 83.9 | 75.3 | 79.6 |
DSO anderer Aktien in der Pharmaeinzelhändler
| Name | DSO | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
 |
Adagene
ADAG
|
53.8 | $ 1.68 | 1.9 % | $ 94.6 M |  China |
 |
Aptorum Group Limited
APM
|
20.6 | $ 1.08 | -0.19 % | $ 5.89 M | China |
 |
Arrowhead Pharmaceuticals
ARWR
|
8.75 | $ 65.3 | 0.46 % | $ 8.73 B |  USA |
 |
Ascendis Pharma A/S
ASND
|
132 | $ 210.55 | 0.86 % | $ 5 B |  Danmark |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
84.7 | - | - | $ 40.3 B | USA |
 |
Alterity Therapeutics Limited
ATHE
|
16.2 K | $ 3.41 | 2.4 % | $ 8.2 B |  Australia |
 |
AgeX Therapeutics
AGE
|
78.4 | - | -10.17 % | $ 12.2 K | USA |
 |
Aeglea BioTherapeutics
AGLE
|
216 | - | - | $ 1.01 B | USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
2.75 K | - | -1.52 % | $ 24.7 M | USA |
 |
Albireo Pharma
ALBO
|
14.7 | - | -0.23 % | $ 916 M | USA |
 |
Midatech Pharma plc
MTP
|
204 | - | -18.52 % | $ 27.3 M |  Britain |
 |
Alpine Immune Sciences
ALPN
|
154 | - | - | $ 2.17 B | USA |
 |
Aravive
ARAV
|
16.8 | - | -13.39 % | $ 1.45 M | USA |
 |
Arena Pharmaceuticals
ARNA
|
946 | - | -6.81 % | $ 3.04 B | USA |
 |
Athersys
ATHX
|
22.6 | - | 3.77 % | $ 22.4 M | USA |
 |
Biogen
BIIB
|
57.9 | $ 187.47 | 0.79 % | $ 27.3 B | USA |
 |
AIkido Pharma
AIKI
|
17.9 | - | 1.93 % | $ 17.4 M | USA |
 |
Acasti Pharma
ACST
|
1.97 | - | 4.01 % | $ 150 M |  Canada |
 |
Adaptimmune Therapeutics plc
ADAP
|
25 | - | -15.15 % | $ 60.3 M | Britain |
 |
Amphastar Pharmaceuticals
AMPH
|
62.6 | $ 27.62 | -0.43 % | $ 1.34 B | USA |
 |
BioXcel Therapeutics
BTAI
|
16.3 | $ 1.98 | -1.0 % | $ 5.02 M | USA |
 |
CureVac N.V.
CVAC
|
13.6 | - | - | $ 867 M |  Germany |
 |
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
169 | $ 11.85 | 4.45 % | $ 766 M | USA |
 |
BioDelivery Sciences International
BDSI
|
115 | - | -4.8 % | $ 255 M | USA |
 |
Axon Enterprise
AXON
|
134 | $ 629.67 | 2.72 % | $ 47.7 B | USA |
 |
Ayala Pharmaceuticals
AYLA
|
61.7 | - | - | $ 7.46 M |  Israel |
 |
Aytu BioScience
AYTU
|
150 | $ 2.65 | -0.38 % | $ 16.6 M | USA |
 |
BeiGene, Ltd.
BGNE
|
49.5 | - | 0.49 % | $ 251 B |  Cayman-islands |
 |
Bellicum Pharmaceuticals
BLCM
|
6.09 | - | -9.72 % | $ 5.89 M | USA |
 |
Acorda Therapeutics
ACOR
|
48.3 | - | -24.86 % | $ 820 K | USA |
 |
Brickell Biotech
BBI
|
254 | - | -5.38 % | $ 6.06 M | USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
28.1 | $ 4.17 | -3.02 % | $ 9.07 B | Israel |
 |
Catalyst Biosciences
CBIO
|
3.24 | $ 10.92 | -0.46 % | $ 719 M | USA |
 |
Berkeley Lights
BLI
|
103 | - | -7.31 % | $ 87 M | USA |